ArticleIn vivo (Athens, Greece)

Clinical Significance of Neoadjuvant Chemotherapy With Gemcitabine Plus S-1 for Resectable Pancreatic Ductal Adenocarcinoma.

Takashi Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.